J Bradley Layton

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 29

Top Venues

Drug safety

Neurology and therapy

PloS one

Clinical endocrinology

RTI Health Solutions

University of North Carolina at Chapel Hill (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

RTI Health Solutions Nov 13 2017

United States

Research Epidemiologist :: Pharmacoepidemiology and Risk Management

University of North Carolina at Chapel Hill Apr 01 2015 - Oct 31 2017

United States

Research Assistant Professor :: Epidemiology

Education History

University of North Carolina at Chapel Hill

United States

PHD :: Epidemiology

Brigham Young University

United States

MSC :: Neuroscience

Publications

J Bradley Layton, Mary E Ritchey, Zhongwen Huang, Shailesh Chavan, Hakan Ay, Nizar Souayah, Colin Anderson-Smits
Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study. Neurology and therapy (2023)
Colin Anderson-Smits, Mary E Ritchey, Zhongwen Huang, Shailesh Chavan, Nizar Souayah, Hakan Ay, J Bradley Layton
Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis. Neurology and therapy (2023)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety (2022)
J Bradley Layton, Joan Forns, Lisa J McQuay, Heather E Danysh, Colleen Dempsey, Mary S Anthony, Mary Ellen Turner
Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
J Bradley Layton, Joan Forns, Lisa J McQuay, Heather E Danysh, Colleen Dempsey, Mary S Anthony, Mary Ellen Turner
Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
J Bradley Layton, Joan Forns, Lisa J McQuay, Heather E Danysh, Colleen Dempsey, Mary S Anthony, Mary Ellen Turner
Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study. Drug safety 46 (2) (2022)
J Bradley Layton, Joan Forns, Lisa J McQuay, Heather E Danysh, Colleen Dempsey, Mary S Anthony, Mary Ellen Turner
Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
J Bradley Layton, Joan Forns, Lisa J McQuay, Heather E Danysh, Colleen Dempsey, Mary S Anthony, Mary Ellen Turner
Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
J Bradley Layton, Joan Forns, Lisa J McQuay, Heather E Danysh, Colleen Dempsey, Mary S Anthony, Mary Ellen Turner
Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study. Drug safety (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
J Bradley Layton, Joan Forns, Lisa J McQuay, Heather E Danysh, Colleen Dempsey, Mary S Anthony, Mary Ellen Turner
Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety (2022)
J Bradley Layton, Joan Forns, Mary Ellen Turner, Colleen Dempsey, Jennifer L Bartsch, Mary S Anthony, Heather E Danysh, Mary E Ritchey, George Demos
Falls and Fractures in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin vs Atypical Antipsychotics: A Cohort Study. Drugs - real world outcomes (2021)
Joan Forns, J Bradley Layton, Jennifer Bartsch, Mary Ellen Turner, Colleen Dempsey, Mary Anthony, Mary E Ritchey, George Demos
Increased risk of falls and fractures in patients with psychosis and Parkinson disease. PloS one 16 (1) (2021)
J Bradley Layton, Wenhong Li, Jiacan Yuan, Joshua P Gilman, Daniel B Horton, Soko Setoguchi
Heatwaves, medications, and heat-related hospitalization in older Medicare beneficiaries with chronic conditions. PloS one 15 (12) (2020)
J Bradley Layton, Dongmei Li, Christoph R Meier, Julie L Sharpless, Til Stürmer, M Alan Brookhart
Injection testosterone and adverse cardiovascular events: A case-crossover analysis. Clinical endocrinology 88 (5) (2018)
J Bradley Layton, Anne M Butler, Catherine A Panozzo, M Alan Brookhart
Rotavirus vaccination and short-term risk of adverse events in US infants. Paediatric and perinatal epidemiology 32 (5) (2018)
Theresa Burkard, Thomas Hügle, J Bradley Layton, Robert J Glynn, Marlene Bloechliger, Noel Frey, Susan S Jick, Christoph R Meier, Julia Spoendlin
Risk of Incident Osteoarthritis of the Hand in Statin Initiators: A Sequential Cohort Study. Arthritis care & research 70 (12) (2018)

J Bradley Layton.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

J Bradley Layton